SBLENDORIO GLENN — SEC Form 4 filings
SEC reporting owner CIK 1277478. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-11 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) | Director | 4 | — | — | 16 |
| Mineralys Therapeutics, Inc. (MLYS) | Director | 3 | — | — | 4 |
| 4D Molecular Therapeutics, Inc. (FDMT) | Director | 2 | — | — | 2 |
Form 4 filings — SBLENDORIO GLENN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Disposition to issuer (D): 142,564 @ $14.50 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 16,236 (derivative) · Disposition to issuer (D): 19,473 (derivative) · Disposition to issuer (D): 18,574 (derivative) · Disposition to issuer (D): 36,111 (derivative) · +4 more | EDGAR |
| 2026-02-20 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 20,414 @ $0 · Grant/award (A): 74,872 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 32,900 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Grant/award (A): 11,847 @ $0 · Grant/award (A): 42,467 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | AMICUS THERAPEUTICS, INC. (FOLD) | Option exercise (M): 15,000 @ $2.80 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1277478 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →